{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:44:09Z","timestamp":1763037849777,"version":"3.37.3"},"reference-count":34,"publisher":"Bentham Science Publishers Ltd.","issue":"13","funder":[{"DOI":"10.13039\/100007834","name":"Ningbo Natural Science Foundation","doi-asserted-by":"publisher","award":["2022J248"],"award-info":[{"award-number":["2022J248"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Reasearch Foundation of Ningbo No.2 Hospital, China","award":["2022HMZD08"],"award-info":[{"award-number":["2022HMZD08"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Nonalcoholic steatohepatitis (NASH) is a common liver injury which will\ndevelop into advanced fibrosis and cirrhosis. This study was designed to identify the different serum\nmetabolites of NASH hamsters and predict the diagnosis biomarkers for NASH.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Golden hamsters were randomly divided into a control group that received a normal diet\nand a NASH group that received a high-fat diet (HFD). After 12 weeks of feeding, the body and\nliver weight of the hamsters were monitored. Serum biochemical parameters and liver histopathological\nchanges were analyzed. Moreover, an untargeted metabolomics analysis based on a GCTOF\/\nMS system was performed to identify the serum differential metabolites between the NASH\nand control groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The liver weight was increased in the NASH group, accompanied by significantly higher\nlevels of serum TC, TG, ALT, AST, LDL-C, and lower HDL-C. HE, Masson, and oil red O staining\nshowed the hepatocyte structure destroyed, lipid droplets accumulated, and fibers proliferated\nin the NASH group. Furthermore, 63 differential metabolites were identified by metabolomic analysis.\nLipids and fatty acids were significantly up-regulated in the NASH group. The top 9 differential\nmetabolites included cholesterol, methyl phosphate, taurine, alpha-tocopherol, aspartic acid,\netc. Metabolites were mainly involved in amino acid metabolism (glycine, cysteine, taurine),\nspermine, fatty acid biosynthesis, urea cycle, bile acid metabolism pathways, etc.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Metabonomics analysis identified 63 differential metabolites in the serum of NASH\nhamsters; among them, lipids and fatty acids had a key role and may be used as biomarkers for the\nearly diagnosis of NASH.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1386207326666230223095745","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T11:56:47Z","timestamp":1677153407000},"page":"2280-2292","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabonomics Application on Screening Serum Biomarkers of Golden\nHamsters with Nonalcoholic Steatohepatitis Induced by High-Fat Diet"],"prefix":"10.2174","volume":"26","author":[{"given":"Jingjing","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Ultrasonic Diagnostic Center, Ningbo No. 2 Hospital, Ningbo Zhejiang 315010, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueliang","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of\nPathology and Pathophysiology, Medical College of Zhejiang University, Hangzhou Zhejiang 310003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunwen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ultrasonic Diagnostic Center, Ningbo No. 2 Hospital, Ningbo Zhejiang 315010, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1038\/s41598-017-05040-6","volume":"7","author":"Tu L.N.","year":"2017","unstructured":"Tu L.N.; Showalter M.R.; Cajka T.; Fan S.; Pillai V.V.; Fiehn O.; Selvaraj V.; Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice. Sci Rep 2017,7(1),6120","journal-title":"Sci Rep"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/oby.21855","volume":"25","author":"Han J.","year":"2017","unstructured":"Han J.; Dzierlenga A.L.; Lu Z.; Billheimer D.D.; Torabzadeh E.; Lake A.D.; Li H.; Novak P.; Shipkova P.; Aranibar N.; Robertson D.; Reily M.D.; Lehman-McKeeman L.D.; Cherrington N.J.; Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model. Obesity 2017,25(6),1069-1076","journal-title":"Obesity"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"101167","DOI":"10.1016\/j.molmet.2021.101167","volume":"50","author":"Ajmera V.","year":"2021","unstructured":"Ajmera V.; Loomba R.; Imaging biomarkers of NAFLD, NASH, and fibrosis. Mol Metab 2021,50,101167","journal-title":"Mol Metab"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1053\/j.gastro.2016.03.005","volume":"150","author":"Younossi Z.","year":"2016","unstructured":"Younossi Z.; Henry L.; Contribution of alcoholic and nonalcoholic fatty liver disease to the burden of liver-related morbidity and mortality. Gastroenterology 2016,150(8),1778-1785","journal-title":"Gastroenterology"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/liv.14869","volume":"41","author":"Cardoso A.C.","year":"2021","unstructured":"Cardoso A.C.; de Figueiredo-Mendes C.; A Villela-Nogueira C.; Current management of NAFLD\/NASH. Liver Int 2021,41(Suppl. 1),89-94","journal-title":"Liver Int"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","volume":"148","author":"Wong R.J.","year":"2015","unstructured":"Wong R.J.; Aguilar M.; Cheung R.; Perumpail R.B.; Harrison S.A.; Younossi Z.M.; Ahmed A.; Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015,148(3),547-555","journal-title":"Gastroenterology"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3390\/ijms17091575","volume":"17","author":"Caligiuri A.","year":"2016","unstructured":"Caligiuri A.; Gentilini A.; Marra F.; Molecular pathogenesis of NASH. Int J Mol Sci 2016,17(9),1575","journal-title":"Int J Mol Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"Chalasani N.","year":"2018","unstructured":"Chalasani N.; Younossi Z.; Lavine J.E.; Charlton M.; Cusi K.; Rinella M.; Harrison S.A.; Brunt E.M.; Sanyal A.J.; The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the study of liver diseases. Hepatology 2018,67(1),328-357","journal-title":"Hepatology"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Younossi Z.","year":"2018","unstructured":"Younossi Z.; Anstee Q.M.; Marietti M.; Hardy T.; Henry L.; Eslam M.; George J.; Bugianesi E.; Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018,15(1),11-20","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/MOG.0000000000000621","volume":"36","author":"Khalifa A.","year":"2020","unstructured":"Khalifa A.; Rockey D.C.; The utility of liver biopsy in 2020. Curr Opin Gastroenterol 2020,36(3),184-191","journal-title":"Curr Opin Gastroenterol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S2468-1253(19)30406-6","volume":"5","author":"Rowe I.A.","year":"2020","unstructured":"Rowe I.A.; Decision making for liver biopsy in NASH, not so FAST? Lancet Gastroenterol Hepatol 2020,5(4),332-334","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/hep.24642","volume":"54","author":"Mato J.M.","year":"2011","unstructured":"Mato J.M.; Lu S.C.; Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers? Hepatology 2011,54(4),1115-1117","journal-title":"Hepatology"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.preteyeres.2018.11.002","volume":"69","author":"La\u00edns I.","year":"2019","unstructured":"La\u00edns I.; Gantner M.; Murinello S.; Lasky-Su J.A.; Miller J.W.; Friedlander M.; Husain D.; Metabolomics in the study of retinal health and disease. Prog Retin Eye Res 2019,69,57-79","journal-title":"Prog Retin Eye Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jchromb.2014.02.043","volume":"966","author":"Bowers J.","year":"2014","unstructured":"Bowers J.; Hughes E.; Skill N.; Maluccio M.; Raftery D.; Detection of hepatocellular carcinoma in hepatitis C patients: Biomarker discovery by LC\u2013MS. J Chromatogr B Analyt Technol Biomed Life Sci 2014,966,154-162","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3177\/jnsv.66.536","volume":"66","author":"Shi C.","year":"2020","unstructured":"Shi C.; Wang L.; Zhou K.; Shao M.; Lu Y.; Wu T.; Targeted metabolomics identifies differential serum and liver amino acids biomarkers in rats with alcoholic liver disease. J Nutr Sci Vitaminol 2020,66(6),536-544","journal-title":"J Nutr Sci Vitaminol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"119823","DOI":"10.1016\/j.biomaterials.2020.119823","volume":"237","author":"Elbadawy M.","year":"2020","unstructured":"Elbadawy M.; Yamanaka M.; Goto Y.; Hayashi K.; Tsunedomi R.; Hazama S.; Nagano H.; Yoshida T.; Shibutani M.; Ichikawa R.; Nakahara J.; Omatsu T.; Mizutani T.; Katayama Y.; Shinohara Y.; Abugomaa A.; Kaneda M.; Yamawaki H.; Usui T.; Sasaki K.; Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model. Biomaterials 2020,237,119823","journal-title":"Biomaterials"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.fsisyn.2019.04.003","volume":"1","author":"Dei Cas M.","year":"2019","unstructured":"Dei Cas M.; Casagni E.; Arnoldi S.; Gambaro V.; Roda G.; Screening of new psychoactive substances (NPS) by gaschromatography\/time of flight mass spectrometry (GC\/MS-TOF) and application to 63 cases of judicial seizure. Forensic Sci Int Synerg 2019,1,71-78","journal-title":"Forensic Sci Int Synerg"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"21833","DOI":"10.3390\/ijms141121833","volume":"14","author":"Imajo K.","year":"2013","unstructured":"Imajo K.; Yoneda M.; Kessoku T.; Ogawa Y.; Maeda S.; Sumida Y.; Hyogo H.; Eguchi Y.; Wada K.; Nakajima A.; Rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Int J Mol Sci 2013,14(11),21833-21857","journal-title":"Int J Mol Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/metabo10040168","volume":"10","author":"Ioannou G.N.","year":"2020","unstructured":"Ioannou G.N.; Nagana Gowda G.A.; Djukovic D.; Raftery D.; Distinguishing NASH histological severity using a multiplatform metabolomics approach. Metabolites 2020,10(4),168","journal-title":"Metabolites"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/biomedicines9040378","volume":"9","author":"Carreres L.","year":"2021","unstructured":"Carreres L.; J\u00edlkov\u00e1 Z.M.; Vial G.; Marche P.N.; Decaens T.; Lerat H.; Modeling diet-induced nafld and nash in rats: A comprehensive review. Biomedicines 2021,9(4),378","journal-title":"Biomedicines"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4314\/ajtcam.v11i1.34","volume":"11","author":"Yang Q.H.","year":"2013","unstructured":"Yang Q.H.; Xu Y.J.; Feng G.F.; Hu C.F.; Zhang Y.P.; Cheng S.B.; Wang Y.P.; Gong X.W.; p38 Mapk signal pathway involved in anti-inflammatory effect of chaihu-shugan-san and shen-lingbai-zhu-san on hepatocyte in non-alcoholic steatohepatitis rats. Afr J Tradit Complement Altern Med 2013,11(1),213-221","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"21721","DOI":"10.1038\/srep21721","volume":"6","author":"Nakatsuka A.","year":"2016","unstructured":"Nakatsuka A.; Matsuyama M.; Yamaguchi S.; Katayama A.; Eguchi J.; Murakami K.; Teshigawara S.; Ogawa D.; Wada N.; Yasunaka T.; Ikeda F.; Takaki A.; Watanabe E.; Wada J.; Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis. Sci Rep 2016,6(1),21721","journal-title":"Sci Rep"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","volume":"60","author":"Kalhan S.C.","year":"2011","unstructured":"Kalhan S.C.; Guo L.; Edmison J.; Dasarathy S.; McCullough A.J.; Hanson R.W.; Milburn M.; Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism 2011,60(3),404-413","journal-title":"Metabolism"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1079\/BJN20051635","volume":"95","author":"Gauthier M.S.","year":"2006","unstructured":"Gauthier M.S.; Favier R.; Lavoie J.M.; Time course of the development of non-alcoholic hepatic steatosis in response to high-fat diet-induced obesity in rats. Br J Nutr 2006,95(2),273-281","journal-title":"Br J Nutr"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jcmgh.2022.06.008","volume":"14","author":"Seike T.","year":"2022","unstructured":"Seike T.; Boontem P.; Yanagi M.; Li S.; Kido H.; Yamamiya D.; Nakagawa H.; Okada H.; Yamashita T.; Harada K.; Kikuchi M.; Shiraishi Y.; Ozaki N.; Kaneko S.; Yamashima T.; Mizukoshi E.; Hydroxynonenal causes hepatocyte death by disrupting lysosomal integrity in nonalcoholic steatohepatitis. Cell Mol Gastroenterol Hepatol 2022,14(4),925-944","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4142\/jvs.2016.17.3.279","volume":"17","author":"Kwak D.H.","year":"2016","unstructured":"Kwak D.H.; Kim J.S.; Chang K.T.; Choo Y.K.; Aristolochia manshuriensis Kom ethyl acetate extract protects against high-fat diet-induced non-alcoholic steatohepatitis by regulating kinase phosphorylation in mouse. J Vet Sci 2016,17(3),279-287","journal-title":"J Vet Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.3748\/wjg.v25.i33.4904","volume":"25","author":"Boland M.L.","year":"2019","unstructured":"Boland M.L.; Or\u00f3 D.; T\u00f8lb\u00f8l K.S.; Thrane S.T.; Nielsen J.C.; Cohen T.S.; Tabor D.E.; Fernandes F.; Tovchigrechko A.; Veidal S.S.; Warrener P.; Sellman B.R.; Jelsing J.; Feigh M.; Vrang N.; Trevaskis J.L.; Hansen H.H.; Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source. World J Gastroenterol 2019,25(33),4904-4920","journal-title":"World J Gastroenterol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/hep.28392","volume":"63","author":"Marchesini G.","year":"2016","unstructured":"Marchesini G.; Petta S.; Dalle Grave R.; Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice. Hepatology 2016,63(6),2032-2043","journal-title":"Hepatology"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","volume":"103","author":"Pierantonelli I.","year":"2019","unstructured":"Pierantonelli I.; Svegliati-Baroni G.; Nonalcoholic fatty liver disease: Basic pathogenetic mechanisms in the progression from NAFLD to NASH. Transplantation 2019,103(1),e1-e13","journal-title":"Transplantation"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2011.06.040","volume":"141","author":"Van Rooyen D.","year":"2011","unstructured":"Van Rooyen D.; Larter C.; Haigh W.; Yeh M.; Ioannou G.; Kuver R.; Lee S.; Teoh N.; Farrell G.; Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. Gastroenterology 2011,141(4),1393-1403","journal-title":"Gastroenterology"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13238-020-00804-9","volume":"12","author":"Jia W.","year":"2021","unstructured":"Jia W.; Wei M.; Rajani C.; Zheng X.; Targeting the alternative bile acid synthetic pathway for metabolic diseases. Protein Cell 2021,12(5),411-425","journal-title":"Protein Cell"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/hep4.1127","volume":"1","author":"Chiang J.Y.L.","year":"2017","unstructured":"Chiang J.Y.L.; Targeting bile acids and lipotoxicity for NASH treatment. Hepatol Commun 2017,1(10),1002-1004","journal-title":"Hepatol Commun"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"R1710","DOI":"10.1152\/ajpregu.00677.2010","volume":"301","author":"Gentile C.L.","year":"2011","unstructured":"Gentile C.L.; Nivala A.M.; Gonzales J.C.; Pfaffenbach K.T.; Wang D.; Wei Y.; Jiang H.; Orlicky D.J.; Petersen D.R.; Pagliassotti M.J.; Maclean K.N.; Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. Am J Physiol Regul Integr Comp Physiol 2011,301(6),R1710-R1722","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3349\/ymj.2021.62.1.21","volume":"62","author":"Jang E.S.","year":"2021","unstructured":"Jang E.S.; Hwang S.H.; Kim J.W.; Jeong S.H.; Effectiveness of 4-week oral taurine treatment for muscle cramps in patients with liver cirrhosis: A single-arm pilot study. Yonsei Med J 2021,62(1),21-28","journal-title":"Yonsei Med J"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207326666230223095745","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/213943\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207326666230223095745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:12:24Z","timestamp":1691079144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/213943\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":34,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207326666230223095745","relation":{},"ISSN":["1386-2073"],"issn-type":[{"type":"print","value":"1386-2073"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}